Zobrazeno 1 - 10
of 37
pro vyhledávání: '"K O, Ng"'
Autor:
Stephanie S. Liu, Karen K. L. Chan, Daniel K. H. Chu, Tina N. Wei, Lesley S. K. Lau, Siew F. Ngu, Mandy M. Y. Chu, Ka Yu Tse, Philip P. C. Ip, Enders K. O. Ng, Annie N. Y. Cheung, Hextan Y. S. Ngan
Publikováno v:
Molecular Oncology, Vol 12, Iss 12, Pp 2009-2022 (2018)
Cervical cancer is one of the leading causes of cancer death in women globally, despite the widespread use of cytology/human papillomavirus (HPV) screening. In the present study, we aimed to identify the potential role of microRNA (miRNA) as a diagno
Externí odkaz:
https://doaj.org/article/3bc6c656406443fda7b1518314a5bd93
Autor:
Yuefeng Wang, Julia Y. S. Tsang, Yongmei Cui, Ji Cui, Ying Lin, Songli Zhao, Patrick T. W. Law, Sai Yin Cheung, Enders K. O. Ng, Gary M. K. Tse, Zunfu Ke
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Abstract Currently, there are no recommended alternative assays for HER2 cases deemed equivocal by immunohistochemistry and fluorescent in situ hybridization. Digital PCR (ddPCR), a highly accurate method to determine DNA copy number, could be a robu
Externí odkaz:
https://doaj.org/article/781a188a1d1d475190ab60b6d48f3515
Autor:
Enders K O Ng, Rufina Li, Vivian Y Shin, Hong Chuan Jin, Candy P H Leung, Edmond S K Ma, Roberta Pang, Daniel Chua, Kent-Man Chu, W L Law, Simon Y K Law, Ronnie T P Poon, Ava Kwong
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53141 (2013)
BackgroundWe previously showed microRNAs (miRNAs) in plasma are potential biomarkers for colorectal cancer detection. Here, we aimed to develop specific blood-based miRNA assay for breast cancer detection.Methodology/principal findingsTaqMan-based mi
Externí odkaz:
https://doaj.org/article/3c87d7ece03e488f909bf810f0b4c798
Autor:
Enders K O Ng, Candy P H Leung, Vivian Y Shin, Chris L P Wong, Edmond S K Ma, Hong Chuan Jin, Kent-Man Chu, Ava Kwong
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e22233 (2011)
BACKGROUND: Previously, we have examined the methylation status of SLC19A3 (solute carrier family 19, member 3) promoter and found that SLC19A3 was epigenetically down-regulated in gastric cancer. Here, we aim to develop a new biomarker for cancer di
Externí odkaz:
https://doaj.org/article/b56af86366ea494b97dc87a8b8159f2e
Autor:
Hc C. Jin, Wp P. Tsang, Christoph Röcken, Tt T. Kwok, S S M Ng, Eko K. O. Ng, Jjy Sung, Jun Yu, Jj J. Li, Mpa P. A. Ebert
Publikováno v:
British Journal of Cancer
Background:MicroRNAs (miRNAs) are 19-25-nucleotides regulatory non-protein-coding RNA molecules that regulate the expressions of a wide variety of genes, including some involved in cancer development. In this study, we investigated the possible role
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kin-Fai, Cheung, Cleo N Y, Lam, Kaichun, Wu, Enders K O, Ng, Wilson W S, Chong, Alfred S L, Cheng, Ka-Fai, To, Daiming, Fan, Joseph J Y, Sung, Jun, Yu
Publikováno v:
Cancer. 118(4)
By using genome-wide methylation screening, the authors identified ring finger protein 180 (RNF180) as preferentially methylated in cancer. This study was undertaken to clarify its structure and functional role in gastric cancer.The transcription sta
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 336
Circulating RNA in plasma and serum is a newly developed area for molecular diagnosis. To date, increasing numbers of studies show that plasma and serum RNA could serve as both tumor- and fetal-specific markers for cancer detection and prenatal diagn
Publikováno v:
Clinical chemistry. 48(10)
Circulating RNA in plasma/serum is an emerging field for noninvasive molecular diagnosis. Because RNA is widely thought to be labile in the circulation, we investigated the stability and various preanalytical factors that may affect RNA concentration